New drug trial targets rare, severe skin disease
NCT ID NCT06295692
Summary
This study is testing an experimental medication called JNJ-77242113 for people with two severe forms of psoriasis: generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). The main goal is to see how well the drug improves skin symptoms and overall condition over 16 weeks. Researchers are also monitoring side effects and quality of life changes in the 19 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dokkyo Medical University Hospital
Shimotsuga Gun, 321 0293, Japan
-
Fujita Health University Hospital
Toyoake, 470-1192, Japan
-
Hospital of the University of Occupational and Environmental Health
Kitakyushu-shi, 807-8556, Japan
-
Ichinomiya Municipal Hospital
Ichinomiya, 491-8558, Japan
-
JR Sapporo Hospital
Hokkaido, 060-0033, Japan
-
Kumamoto University Hospital
Kumamoto, 860-8556, Japan
-
Mie University Hospital
Tsu, 514 8507, Japan
-
Nagoya City University Hospital
Nagoya, 467 8602, Japan
-
Public Interest Incorporated Foundation Nipoon Life Saiseikai Nippon Life Hospital
Osaka, 550 0006, Japan
-
Teikyo University Hospital
Itabashi Ku, 173 8606, Japan
-
Tohoku University Hospital
Sendai, 980 8574, Japan
-
Tokyo Medical University Hospital
Shinjuku, 160 0023, Japan
Conditions
Explore the condition pages connected to this study.